Complementary approaches in fetal genetic diagnosis: Decision-making process and alternative choices for clinicians in a secondary health care institution

dc.authorid0000-0001-6574-8149en_US
dc.authorid0000-0001-5218-7880en_US
dc.contributor.authorBolat, Hilmi
dc.contributor.authorÇelebi, Hamide Betül Gerik
dc.contributor.authorKarahanoğlu, Ertuğrul
dc.date.accessioned2022-04-12T11:44:07Z
dc.date.available2022-04-12T11:44:07Z
dc.date.issued2021en_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.descriptionBolat, Hilmi (Balikesir Author)en_US
dc.description.abstractObjectives: The aim of this study was to determine indications of invasive, genetic results of conventional karyotyping and chromosomal microarray analysis and culture failure rates to discuss possible solution options and guide our clinical choices. Materials and methods: Fetal samples were analyzed by conventional karyotyping, array comparative genomic hybridization, fluorescence in situ hybridization. Results: Failure rates of chorionic villus sampling (CVS) and amniocentesis were as follows, respectively: 4.5% and 0.4%. The rates of abnormal genetic results in fetuses with only thickened nuchal translucency and thickened nuchal translucency+USG abnormality were %4.2 and %40, respectively. Conclusions: Abnormal genetic results showed a significant increase in cases of thickened nuchal translucency accompanied by USG abnormalities. Although culture failure rates in the CVS were higher, none of the cases remained inconclusive. Centers with prenatal invasive genetic diagnosis should offer a wide spectrum of genetic tests by medical genetics specialists.en_US
dc.identifier.doi10.1080/15513815.2021.2022818
dc.identifier.endpage11en_US
dc.identifier.issn1551-3815
dc.identifier.issn1551-3823
dc.identifier.scopus2-s2.0-85122240108
dc.identifier.scopusqualityQ2
dc.identifier.startpage1en_US
dc.identifier.urihttps://doi.org/10.1080/15513815.2021.2022818
dc.identifier.urihttps://hdl.handle.net/20.500.12462/12177
dc.identifier.volumeEarly Access DEC 2021en_US
dc.identifier.wosWOS:000737657900001
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherTaylor & Francis Incen_US
dc.relation.ispartofFetal and Pediatric Pathologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectChromosome Abnormalityen_US
dc.subjectaCGHen_US
dc.subjectPrenatal Diagnosisen_US
dc.subjectUltrasound Abnormalitiesen_US
dc.subjectGenetic Counselingen_US
dc.titleComplementary approaches in fetal genetic diagnosis: Decision-making process and alternative choices for clinicians in a secondary health care institutionen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
hilmi-bolat.pdf
Boyut:
918.07 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: